Inflammatory response in the acute phase of deep vein thrombosis

Journal of Vascular Surgery
E M Roumen-KlappeH Wollersheim

Abstract

Deep vein thrombosis (DVT) is a multifactorial disease. Recently, inflammation has been suggested as a risk factor for DVT. The question is whether inflammation is a cause of venous thrombosis or rather a result of the thrombotic process. We studied the inflammatory response in the acute phase of DVT with interleukin-6, interleukin-8, and C-reactive protein (CRP) as inflammatory markers. Plasma concentrations were measured on the day of admission (day 0) in 40 patients with acute DVT confirmed with phlebography and in 33 patients with clinical suspicion of DVT but negative phlebography results (controls). In patients with DVT, inflammatory markers were also examined on five subsequent days. On day 0, the median concentrations in plasma of interleukin-6, interleukin-8, and CRP were 15.0 pg/mL (range, <3 to 70 pg/mL), 7.0 pg/mL (range, <3 to 76 pg/mL), 37.5 mg/L (range, <7 to 164 mg/L), respectively, in the patient group and less than 3 pg/mL (range, <3 to 11 pg/mL; P <.001), 6.0 pg/mL (range, <3 to 52 pg/mL; P =.08), and 5.0 pg/L (range, <7 to 66 pg/L; P <.001), respectively, in the controls. During the next days, interleukin-6 concentration showed a gradual decline in patients with DVT from 15.0 to 5.5 pg/mL (P <.001), interleu...Continue Reading

References

Jun 1, 1990·Journal of Clinical Pathology·H SyrjäläH Kiviniemi
Apr 3, 1997·The New England Journal of Medicine·P M RidkerC H Hennekens
Apr 21, 1999·Lancet·F R Rosendaal
Feb 9, 2000·Journal of Vascular Surgery·T W WakefieldL J Greenfield
Mar 9, 2000·The New England Journal of Medicine·J C MeijersF R Rosendaal
Oct 29, 2000·Journal of Vascular Surgery·M H MeissnerD E Strandness

❮ Previous
Next ❯

Citations

Jan 27, 2012·Journal of Thrombosis and Thrombolysis·April L RodriguezJose A Diaz
Dec 17, 2008·Current Opinion in Rheumatology·Gunnar TomassonPeter A Merkel
Jan 18, 2011·Hematology·Susan R Kahn
Sep 11, 2009·Blood·Susan R Kahn
Mar 18, 2011·The Journal of Rheumatology·Gunnar TomassonUNKNOWN Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
Oct 4, 2012·Thrombosis Research·Bruna M MazettoJoyce M Annichino-Bizzacchi
Jan 26, 2011·Thrombosis Research·Susan R Kahn
Dec 7, 2010·Annals of Vascular Surgery·Brandon M WojcikJose A Diaz
Jul 11, 2006·British Journal of Haematology·Susan R Kahn
Jan 30, 2009·Journal of Thrombosis and Haemostasis : JTH·E M Roumen-KlappeM Den Heijer
Jun 16, 2010·Journal of Thrombosis and Haemostasis : JTH·Y I G V TichelaarW M Lijfering
Mar 30, 2016·The Journal of Surgical Research·Ziyang ZhangBaoqin Lin
May 6, 2006·International Journal of Cardiology·Natale Daniele BrunettiMatteo Di Biase
Feb 28, 2006·Thrombosis Research·Edelmiro ReganonJusto Aznar
Mar 20, 2016·Journal of Vascular Surgery. Venous and Lymphatic Disorders·Anat RabinovichUNKNOWN BioSOX Investigators
Apr 27, 2016·Thrombosis Research·Ibrahim O BalogunRoopen Arya
Feb 15, 2015·Annals of Hematology·Juan-Carlos Hernández-BoludaUNKNOWN Grupo Español de Enfermedades Mieloproliferativas Filadelfia Negativas (GEMFIN)
Nov 16, 2010·Journal of Vascular Surgery·Robert B McLafferty
Apr 12, 2003·The American Journal of Medicine·Daniel J BrotmanThomas S Kickler
Oct 30, 2016·Journal of Surgical Oncology·Ivy N HaskinsSamir Agarwal
Aug 29, 2009·European Journal of Internal Medicine·E BruinstroopM V Huisman
Sep 25, 2016·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Mateja Kaja JezovnikPavel Poredos
Jan 21, 2016·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Mariana KrutmanNelson Wolosker
Jul 3, 2013·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Eftal Murat BakirciMahmut Acikel
Nov 10, 2011·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Jan P BembenekAnna Czlonkowska
Aug 12, 2010·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Nurdan KöktürkNuman Ekim
Apr 27, 2017·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Yaping FengMingyi Zhang
Oct 19, 2012·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Luis Fernando BittarJoyce M Annichino-Bizzacchi
Apr 26, 2007·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Luca Masotti, Roberto Cappelli
Apr 30, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Sandrine LauranceMark D Blostein

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cardiovascular and Interventional Radiology
S RoyK S Sakariassen
The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Ronen Ben-JosephEyal Sheiner
International Angiology : a Journal of the International Union of Angiology
J HirmerovaJ Filipovsky
© 2022 Meta ULC. All rights reserved